SCHEMBL648530

SCHEMBL648530

CC=[Zr](Cl)(Cl)(c1cccc2c1Cc1ccccc1-2)c1cccc2c1Cc1ccccc1-2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.44
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
PGR P06401 1/20 0.35
MAP3K9 P80192 1/20 0.33
MAP3K11 Q16584 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
MAOA P21397 1/20 0.33
BCHE P06276 2/20 0.33
ACHE P22303 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3112715 0.83 PNMT (0.44) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL9226145 0.83 PNMT (0.44) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL1130363 0.82 PNMT (0.42) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL9217933 0.80 PNMT (0.41) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL7641126 0.79 PNMT (0.46) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL7716985 0.79 PNMT (0.46) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL5351418 0.79 PNMT (0.42) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL5836874 0.79 NPC1 (0.48) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL7783628 0.79 PNMT (0.42) PNMTNPC1RAB9AHTR7HTR2B
SCHEMBL3119422 0.79 PNMT (0.42) PNMTNPC1RAB9AHTR7HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1852408-B1 PROCESS FOR THE DIMERIZATION OF ALPHA-OLEFINS IDEMITSU KOSAN CO (JP) 2018-04-04 EP disclosed
US-20130225892-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-08-29 US disclosed
WO-2012133936-A1 CATALYST FOR PRODUCING ETHYLENE-BASED POLYMER AND METHOD FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-04 WO disclosed
WO-2012133919-A1 PROCESS FOR PRODUCING CATALYST FOR PRODUCING ETHYLENIC POLYMER, CATALYST FOR PRODUCING ETHYLENIC POLYMER AND PROCESS FOR PRODUCING ETHYLENIC POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-04 WO disclosed
US-20120088946-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2012-04-12 US disclosed
US-8119850-B2 Process for producing unsaturated hydrocarbon compound IDEMITSU KOSAN CO., LTD. (JP) 2012-02-21 US disclosed
US-7714087-B2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2010-05-11 US disclosed
EP-1734061-B1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof MITSUI CHEMICALS INC (JP) 2010-04-07 EP disclosed
US-20090137757-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof IMUTA JUNICHI 2009-05-28 US disclosed
US-20090069614-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2009-03-12 US disclosed
EP-1186619-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof Mitsui Chemicals, Inc. (JP) 2002-03-13 EP disclosed
US-6121394-A Metallocene-catalyzed olefin polymerization in the absence of aluminoxane MITSUI CHEMICALS, INC. (JP) 2000-09-19 US disclosed
EP-0846122-B1 BRIDGED METALLOCENE COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN CATALYSTS FOR THE POLYMERIZATION OF OLEFINS MONTELL TECHNOLOGY COMPANY BV (NL) 2000-07-05 EP disclosed
EP-0500944-B1 CATALYST FOR ALPHA-OLEFIN POLYMERIZATION AND PRODUCTION OF POLY-ALPHA-OLEFIN THEREWITH MITSUI CHEMICALS INC (JP) 1998-10-07 EP disclosed
EP-0841349-A2 Catalyst for alpha-olefin polymerization and production of poly-alpha-olefin therewith MITSUI TOATSU CHEMICALS, Inc. (JP) 1998-05-13 EP disclosed
EP-0283164-B1 Cyclo-olefinic random copolymer, olefinic random copolymer, and process for producing cyclo-olefinic random copolymers MITSUI PETROCHEMICAL IND (JP) 1995-05-24 EP disclosed
EP-0500944-A1 CATALYST FOR $g(a)-OLEFIN POLYMERIZATION AND PRODUCTION OF POLY-$g(a)-OLEFIN THEREWITH MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-09-02 EP disclosed
US-5008356-A Copolymerization using coordination catalysts MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-04-16 US disclosed
US-5003019-A Radiation transparent, heat resistant, solvent resistant copolymer MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1991-03-26 US disclosed
EP-0283164-A2 Cyclo-olefinic random copolymer, olefinic random copolymer, and process for producing cyclo-olefinic random copolymers MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069614-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND AHR, ALOX12, ARNT PNMT 2343/4885NPC1 684/4885RAB9A 4259/4885
US-20120088946-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND ALOX12, ALOX15B, ALOX15 PNMT 1509/4885NPC1 1027/4885RAB9A 4335/4885
US-20130225892-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND ALOX12, ALOX15B, ALOX15 PNMT 1509/4885NPC1 1027/4885RAB9A 4335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.